| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/21/2010 | US20100016333 Once-a-day (RNA-Polymerase Inhibiting or phenazine) - dihydropteroate synthase inhibiting - dihydrofolate reductase inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by Methicillin-Resistant Staphylococcus aureus |
| 01/21/2010 | US20100016313 Intestinal alkaline phosphatase modulators and uses thereof |
| 01/21/2010 | US20100016311 Novel minor groove binders |
| 01/21/2010 | US20100016297 Alkyl-substituted 3' compounds having 5-ht6 receptor affinity |
| 01/21/2010 | US20100016276 Compositions and methods for the identification of a carbapenemase gene |
| 01/21/2010 | US20100016262 Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis |
| 01/21/2010 | US20100016253 Methods and compositions related to heightened apobec-1 related protein (arp) expression |
| 01/21/2010 | US20100016251 Nucleoside phosphoramidate prodrugs |
| 01/21/2010 | US20100016250 Toll-like receptor 9 agonists |
| 01/21/2010 | US20100016244 D-glucopyranose 1-[3,5-bis (1,1-dimethylethy)-4-hydroxybenzoate] and its derivatives, preparation and use thereof |
| 01/21/2010 | US20100016225 CONJUGATES COMPRISED OF POLYMER AND HIV gp-41-DERIVED PEPTIDES AND THEIR USE IN THERAPY |
| 01/21/2010 | US20100016224 Compositions and methods for modulating an immune response |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100016208 Photoactivatable antimicrobial agents |
| 01/21/2010 | US20100015593 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 01/21/2010 | US20100015253 Treatment of nail infections with no |
| 01/21/2010 | US20100015248 Pharmaceutical composition |
| 01/21/2010 | US20100015214 Novel Trans-Adjuvant System |
| 01/21/2010 | US20100015211 Combination Approaches For Generating Immune Responses |
| 01/21/2010 | US20100015208 Antibacterial wound dressing |
| 01/21/2010 | US20100015207 Methods for Treating Oral Cavity Infections with Chlorine Dioxide |
| 01/21/2010 | US20100015179 Attenuation of encephalitogenic alphavirus and uses thereof |
| 01/21/2010 | US20100015178 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/21/2010 | US20100015177 Method for Preserving Viral Particles |
| 01/21/2010 | US20100015175 Vaccine |
| 01/21/2010 | US20100015174 Method to control dengue viruses in humans by picolinic acid and derivatives thereof |
| 01/21/2010 | US20100015173 Coiled-coil lipopeptide helical bundles and synthetic virus-like particles |
| 01/21/2010 | US20100015165 Two Step Miniemulsion Process |
| 01/21/2010 | US20100015138 Crystal structure of Staphylococcus aureus clumping factor a in complex with fibrinogen derived peptide and uses thereof |
| 01/21/2010 | US20100015126 Methods of Binding of Cross-Beta Structures By Chaperones |
| 01/21/2010 | US20100015098 Isolated phages and their use in food or pet food products |
| 01/21/2010 | US20100015096 Fusion Proteins of Mycobacterium Tuberculosis |
| 01/21/2010 | US20100015094 Antiviral nucleoside analogs |
| 01/21/2010 | US20100015093 Methods and compositions of treating a flaviviridae family viral infection |
| 01/21/2010 | US20100015092 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
| 01/21/2010 | US20100015087 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 01/21/2010 | US20100015084 Compounds for Treating Papilloma Virus Infection |
| 01/21/2010 | US20100015083 Method of producing pvp/fullerene complex and aqueous solution thereof |
| 01/21/2010 | US20100015063 Benzodiazepine Derivatives and Pharmaceutical Compositions Containing Them |
| 01/21/2010 | US20100015046 Camptothecin-Binding Moiety Conjugates |
| 01/21/2010 | CA2734714A1 Vaccines comprising tb10.4 |
| 01/21/2010 | CA2731218A1 Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
| 01/21/2010 | CA2731194A1 Chimeric respiratory syncytial virus polypeptide antigens |
| 01/21/2010 | CA2730929A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | CA2730843A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | CA2730826A1 Antibacterial combination therapy for the treatment of gram positive bacterial infections |
| 01/21/2010 | CA2730737A1 Immunogenic amphipathic peptide compositions |
| 01/21/2010 | CA2730668A1 New influenza virus immunizing epitope |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/20/2010 | EP2145961A2 Porcine adenovirus type 3 genome |
| 01/20/2010 | EP2145891A1 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| 01/20/2010 | EP2144932A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 01/20/2010 | EP2144931A2 Monoclonal antibodies against dengue and other viruses with deletion in fc region |
| 01/20/2010 | EP2144924A1 Fusion protein vaccine |
| 01/20/2010 | EP2144904A1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent |
| 01/20/2010 | EP2144617A1 Delivery of flu antibodies to surfaces in contact with air |
| 01/20/2010 | EP2003140B1 Galactose derivative, drug carrier and medicinal composition |
| 01/20/2010 | EP1809653B1 Substituted nonadepsipeptides |
| 01/20/2010 | EP1506214B1 6-11 bicyclic ketolide derivatives |
| 01/20/2010 | EP1474114B1 Oral dosage form for controlled drug release |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1427396B1 Dosage forms having prolonged active ingredient release |
| 01/20/2010 | EP1379272B1 Monoclonal antibodies directed against molecular mimetics of meningococcal b epitopes |
| 01/20/2010 | EP1313422B1 Non-hormonal vaginal contraceptive |
| 01/20/2010 | EP1267880B2 Low dose entecavir formulation and use |
| 01/20/2010 | CN101628933A HIV peptides from tat, rev and wef conserved and their application as e.g. vaccine components |
| 01/20/2010 | CN100582215C Megasphaera elsdenii strain and its uses |
| 01/20/2010 | CN100582109C Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/20/2010 | CN100582106C Pyrrolidine sulfsulopenem derivative preparation method and its intermediate |
| 01/20/2010 | CN100582097C Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581580C Oral administration medicinal broth for treating pulmonary tuberculosis |
| 01/20/2010 | CN100581574C Medicine for treating pulmonary tuberculosis |
| 01/20/2010 | CN100581565C Traditional Chinese medicine compositions for AIDS and its preparation method and uses |
| 01/20/2010 | CN100581562C Preparation method for separating and purifying extractive from lotus leaves, and usage |
| 01/20/2010 | CN100581560C Cold-treating medicine and preparation method thereof |
| 01/20/2010 | CN100581555C Viable prebiotics bacteria microcapsule preparations for livestock and method for preparing the same |
| 01/20/2010 | CN100581545C Siromosi medicinal composition and its making method |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649085 Saquinavir conjugates and antibodies useful in immunoassay |
| 01/19/2010 | US7649080 Reacting vancomycin with a coupling reagent, then reacting with a cephalosporin derivative; making antibiotic effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 01/19/2010 | US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/19/2010 | US7649012 Compounds, pharmaceutical compositions containing same, and methods of use for same |
| 01/19/2010 | US7648999 Activator for peroxisome proliferator-activated receptor δ |
| 01/19/2010 | US7648997 Immunomodulators for inducing cytokine biosynthesis, for treatment of diseases including viral and neoplastic diseases; 1-[3-(Aminooxy)propyl]-2-propyl-1H-imidazo[4,5-c]quinolin-4-amine; N-[3-(4-Amino-2-propyl-1H-imidazo[4,5-c]quinolin-1-yl)propoxy]cyclopropanecarboxamide |
| 01/19/2010 | US7648967 Using isoguanosine nucleoside analogs, and derivatives thereof, in cell cultures and in antiviral therapy; increasing the mutation rate of a virus such as bovine viral diarrhea virus and hepatitis C virus |
| 01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |
| 01/19/2010 | US7648707 Compositions and methods for treatment of microbial infections |
| 01/19/2010 | US7648695 A halogenated xanthene derivative, preferably Rose Bengal; can be delivered at high concentrations to certain tissues |
| 01/19/2010 | CA2465928C Synthesis and purification of valacyclovir |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2315897C Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 01/19/2010 | CA2301891C Rna respiratory synctial virus vaccines |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/19/2010 | CA2164517C Method of treating retained pulmonary secretions |
| 01/14/2010 | WO2010006315A2 Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and intiviral, antibacterial, and anticancer agents |
| 01/14/2010 | WO2010005986A1 Salts of hiv inhibitor compounds |
| 01/14/2010 | WO2010005958A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | WO2010005836A2 Use of rifalazil to treat colonic disorders |
| 01/14/2010 | WO2010005637A2 Electrostatically charged multi-acting nasal application, product, and method |